Lorlagen (Lorlatinib), generic Lorbrena is a prescription medicine that is used to treat metastatic non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Lorlatinib is used in patients who have already received alectinib, ceritinib, or both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the ALK gene. Lorlagen is manufactured by General Pharmaceuticals Ltd. in Bangladesh.
Related products
- Anti-Cancer
Alecnib 150 mg (Alectinib)
- Anti-Cancer
Tofacinix 11 mg (Tofacitinib)
- Anti-Cancer
Regonix 40 mg (Regorafenib)
- Anti-Cancer
Palbonix 125 mg (Palbociclib)
- Anti-Cancer
Dasanix 20 mg (Dasatinib)
- Lung Cancer
Afanix 40 mg (Afatinib)